Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study.

Torres T, Sood S, Yilmaz O, Vender RB, Prajapati VH, Puig L, Megna M, Marzano AV, Gisondi P, Carrascosa JM, Dauden E, Llamas-Velasco M, Balato A, Leal BG, Prignano F, Bellinato F, Silvi G, Di Brizzi EV, Potestio L, Carrera CG, López-Ferrer A, Del-Alcazar E, Mufti A, Maul LV, Piaserico S, Maul JT, Yeung J

Open source

DOI: 10.1007/s13555-026-01653-w
Published: 2026 Feb
Container: Dermatology and therapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13555-026-01653-w,
  title = {Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study.},
  author = {Torres T and Sood S and Yilmaz O and Vender RB and Prajapati VH and Puig L and Megna M and Marzano AV and Gisondi P and Carrascosa JM and Dauden E and Llamas-Velasco M and Balato A and Leal BG and Prignano F and Bellinato F and Silvi G and Di Brizzi EV and Potestio L and Carrera CG and López-Ferrer A and Del-Alcazar E and Mufti A and Maul LV and Piaserico S and Maul JT and Yeung J},
  year = {2026},
  journal = {Dermatology and therapy},
  doi = {10.1007/s13555-026-01653-w},
  url = {https://doi.org/10.1007/s13555-026-01653-w}
}

RIS

TY  - JOUR
TI  - Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study.
AU  - Torres T
AU  - Sood S
AU  - Yilmaz O
AU  - Vender RB
AU  - Prajapati VH
AU  - Puig L
AU  - Megna M
AU  - Marzano AV
AU  - Gisondi P
AU  - Carrascosa JM
AU  - Dauden E
AU  - Llamas-Velasco M
AU  - Balato A
AU  - Leal BG
AU  - Prignano F
AU  - Bellinato F
AU  - Silvi G
AU  - Di Brizzi EV
AU  - Potestio L
AU  - Carrera CG
AU  - López-Ferrer A
AU  - Del-Alcazar E
AU  - Mufti A
AU  - Maul LV
AU  - Piaserico S
AU  - Maul JT
AU  - Yeung J
PY  - 2026
JO  - Dermatology and therapy
DO  - 10.1007/s13555-026-01653-w
UR  - https://doi.org/10.1007/s13555-026-01653-w
ER  -

APA

T, T., S, S., O, Y., RB, V., VH, P., L, P., M, M., AV, M., P, G., JM, C., E, D., M, L., A, B., BG, L., F, P., F, B., G, S., EV, D. B., L, P., CG, C., A, L., E, D., A, M., LV, M., S, P., JT, M., & J, Y. (2026). Real-World Effectiveness and Safety of Tildrakizumab for Plaque Psoriasis: A 3-Year International Multicenter Retrospective Study.. Dermatology and therapy. https://doi.org/10.1007/s13555-026-01653-w

Source records

pubmed · retrieved 2026-09-25T21:41:57.364Z